Zenapax humanized antibody targeted to T cells: Phase I/II trial

Protein Design Labs Inc.

Read the full 47 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE